Peer support for people with alcohol dependence

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PEERSIAD study explores the use of addiction peer support specialists to aid adults with alcohol use disorder who have completed initial detox. Participants receive peer support consultations and complete quality-of-life assessments to gauge impact on engagement and well-being. The trial compares outcomes after introducing APSS-supported care within post-detox outpatient programs, aiming to see if peer involvement improves retention and clinical measures. Eligible participants are adults in France who meet DSM-5 criteria for AUD, are abstinent during a defined detox window, and start a post-detox outpatient program. Safety and feasibility are assessed through standard quality-of-life instruments alongside routine clinical follow-up.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged ≥ 18
* Socially insured
* Meeting DSM-5 criteria for alcohol use disorder (AUD)
* Abstinent from alcohol and involved in supervised alcohol withdrawal for at least 5 days and no more than 21 days (outpatient or inpatient)
* Starting a post-detoxification outpatient program

Exclusion Criteria:

* Other severe substance use disorder, i.e. DSM-5 criteria ≥ 6 (excluding tobacco)
* Patient under protective measure (safeguard measure, guardianship) or deprived of liberty or in ordered care and hospitalization measures without consent.
* Inability to communicate and express oneself orally in French, compromising the possibility of exchanges between the Peer support and the patient.
* Psychiatric or cognitive comorbidities making inclusion impossible, at the investigator's discretion.
* Individual accompaniment by a Peer support in the 15 days prior to inclusion.

Where it's running

• CH Le Vinatier
  Bron, France Recruiting
• Hôpital Beaujon
  Clichy, France Not yet recruiting
• GH Nord, Hospices Civils de Lyon
  Lyon, France Not yet recruiting
• CHS St Anne
  Paris, France Not yet recruiting
• Bichat Hospital
  Paris, France Not yet recruiting

Study contacts

• Principal investigator: Benjamin ROLLAND — Hopsices Civils de Lyon
• Study coordinator: Benjamin ROLLAND, Professor
• Email: Benjamin.ROLLAND@chu-lyon.fr
• Phone: 04 37 91 50 75

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

• Thiamine to reduce brain injury in adults with alcohol use disorder

  This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.

  Recruiting Phase 2 Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT07844720

• Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit

  This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.

  Recruiting Brandeis University · Detroit, Michigan · NCT07724275

• Path180: a computer-based skills program to help teens reduce alcohol use

  This 8-week trial tests Path180, a computer-based skills training, added to usual care for teens 13–19 with alcohol use disorder to see if it improves daily-life coping skills and outcomes.

  Recruiting Brown University · Providence, Rhode Island · NCT07713251

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)

  This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.

  Recruiting Phase 3 Centre Hospitalier Universitaire de Nīmes · Bayonne and 7 other locations · NCT07638553

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.